4.8 Review

Ferroptosis: molecular mechanisms and health implications

Journal

CELL RESEARCH
Volume 31, Issue 2, Pages 107-125

Publisher

SPRINGERNATURE
DOI: 10.1038/s41422-020-00441-1

Keywords

-

Categories

Funding

  1. Ligue contre le Cancer (equipe labellisee)
  2. Agence National de la Recherche (ANR) - Projets blancs
  3. ANR
  4. AMMICa
  5. Association pour la recherche sur le cancer (ARC)
  6. Association Le Cancer du Sein, Parlons-en!
  7. Canceropole Ile-de-France
  8. Chancelerie des universites de Paris (Legs Poix), Fondation pour la Recherche Medicale (FRM)
  9. European Research Area Network on Cardiovascular Diseases (ERA-CVD, MINOTAUR)
  10. Gustave Roussy Odyssea
  11. European Union Horizon 2020 Project Oncobiome
  12. Fondation Carrefour
  13. High-end Foreign Expert Program in China, Institut National du Cancer (INCa) [GDW20171100085]
  14. Inserm (HTE)
  15. Institut Universitaire de France
  16. LeDucq Foundation
  17. LabEx Immuno-Oncology [ANR-18-IDEX-0001]
  18. RHU Torino Lumiere
  19. Seerave Foundation
  20. SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE)
  21. SIRIC Cancer Research and Personalized Medicine (CARPEM)
  22. US National Institutes of Health [R01CA160417, R01CA211070]

Ask authors/readers for more resources

Cell death can be executed through different subroutines, such as ferroptosis which is an iron-dependent form of non-apoptotic cell death. Ferroptosis can occur through two major pathways, driven by redox imbalance and abnormal expression of redox-active enzymes. The process is precisely regulated at multiple levels, with the transcription factor NFE2L2 playing a central role in anti-ferroptotic defense.
Cell death can be executed through different subroutines. Since the description of ferroptosis as an iron-dependent form of non-apoptotic cell death in 2012, there has been mounting interest in the process and function of ferroptosis. Ferroptosis can occur through two major pathways, the extrinsic or transporter-dependent pathway and the intrinsic or enzyme-regulated pathway. Ferroptosis is caused by a redox imbalance between the production of oxidants and antioxidants, which is driven by the abnormal expression and activity of multiple redox-active enzymes that produce or detoxify free radicals and lipid oxidation products. Accordingly, ferroptosis is precisely regulated at multiple levels, including epigenetic, transcriptional, posttranscriptional and posttranslational layers. The transcription factor NFE2L2 plays a central role in upregulating anti-ferroptotic defense, whereas selective autophagy may promote ferroptotic death. Here, we review current knowledge on the integrated molecular machinery of ferroptosis and describe how dysregulated ferroptosis is involved in cancer, neurodegeneration, tissue injury, inflammation, and infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available